Prophylaxis of hepatitis B after liver transplantation with antiviral(s) and immunoglobulins efficiently protect the majority of recipients; however recent experiences suggest a decline of HBsAg-positive candidates and the use of hepatitis B Immunoglobulin-free schedules.
Prevalent use of combined prophylaxis of hepatitis B after liver transplantation in Italy: results of a national survey in a large cohort / Marzano, A., Andreone, P., Boccagni, P., Burra, P., Caneschi, F., Conoscitore, P.F., Coppola, C., De Carlis, L., Fagiuoli, S., Forte, P., Gaeta, G.B., Iemmolo, R.M., Lotti Suffredini, A., Mazzola, M., Merli, M., Parrilli, G., Piai, G., Piras, M.R., Salizzoni, M., Tamè, M., et al.. - In: MINERVA GASTROENTEROLOGICA E DIETOLOGICA. - ISSN 1827-1642. - 64:1(2018), pp. 1-9. [10.23736/S1121-421X.17.02407-2]
Prevalent use of combined prophylaxis of hepatitis B after liver transplantation in Italy: results of a national survey in a large cohort
Andreone, Pietro;
2018
Abstract
Prophylaxis of hepatitis B after liver transplantation with antiviral(s) and immunoglobulins efficiently protect the majority of recipients; however recent experiences suggest a decline of HBsAg-positive candidates and the use of hepatitis B Immunoglobulin-free schedules.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
